Jason Hsu, Director at Immix Biopharma, Inc. (IMMX), bought 3,965,913 shares at $5.00 ($3.6M) on 2021-12-20, disclosed to the SEC on 2021-12-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.85 | 3,915,913 | $3.3M | 93.0% |
| 2 | $5.00 | 50,000 | $250K | 7.0% |
| Total | $0.90 avg | 3,965,913 | $3.6M | 100% |
| Filing → |
| IMMX | BUY | 2024-07-31 | $20K | — | Filing → |
| IMMX | BUY | 2023-12-12 | $267K | — | Filing → |
| IMMX | BUY | 2023-09-18 | $200K | — | Filing → |